Use of the Activating Gene Mutation of the Tyrosine Kinase (VAL617Phe) JAK2 as a Minimal Residual Disease Marker in Patients With Myelofibrosis and Myeloid Metaplasia After Allogeneic Stem Cell Transplantation

Tyrosine Kinase ◽

Gene Mutation ◽

Residual Disease ◽

Myeloid Metaplasia ◽

Disease Marker ◽

Impact of pre-transplantation minimal residual disease determined by multiparameter flow cytometry on the outcome of AML patients with FLT3-ITD after allogeneic stem cell transplantation

Annals of Hematology ◽

10.1007/s00277-018-3265-1 ◽

2018 ◽

Vol 97 (6) ◽

pp. 967-975 ◽

Cited By ~ 10

Author(s):

Xiaosu Zhao ◽

Zhidong Wang ◽

Guorui Ruan ◽

Yanrong Liu ◽

Yu Wang ◽

...

Keyword(s):

Flow Cytometry ◽

Stem Cell ◽

Cell Transplantation ◽

Residual Disease ◽

Multiparameter Flow Cytometry ◽

Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia

Leukemia ◽

10.1038/sj.leu.2402198 ◽

2001 ◽

Vol 15 (9) ◽

pp. 1485-1487 ◽

Cited By ~ 74

Author(s):

VHJ van der Velden ◽

SA Joosten ◽

MJ Willemse ◽

ER van Wering ◽

AW Lankester ◽

...

Keyword(s):

Stem Cell ◽

Acute Lymphoblastic Leukemia ◽

Quantitative Pcr ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Real Time Quantitative Pcr ◽

Preemptive Treatment of Minimal Residual Disease (MRD) with IL-15-Activated Cytokine-Induced Killer Cells for the Prevention of Relapse in Leukemia Patients after Allogeneic Stem Cell Transplantation – Results of a Pilot Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.11.324 ◽

2016 ◽

Vol 22 (3) ◽

pp. S43 ◽

Cited By ~ 1

Author(s):

Peter Bader ◽

Sabine Huenecke ◽

Halvard Bönig ◽

Michael Merker ◽

Andrea Jarisch ◽

...

Keyword(s):

Stem Cell ◽

Pilot Study ◽

Cell Transplantation ◽

Residual Disease ◽

Killer Cells ◽

Prevention Of Relapse ◽

New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation

International Journal of Hematologic Oncology ◽

10.2217/ijh.13.4 ◽

2013 ◽

Vol 2 (1) ◽

pp. 39-48 ◽

Cited By ~ 7

Author(s):

Lindsay AM Rein ◽

Anthony D Sung ◽

David A Rizzieri

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Residual Disease ◽

New Approaches ◽

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

Leukemia ◽

10.1038/leu.2012.352 ◽

2012 ◽

Vol 27 (6) ◽

pp. 1254-1262 ◽

Cited By ~ 123

Author(s):

H Pfeifer ◽

◽

B Wassmann ◽

W Bethge ◽

J Dengler ◽

...

Keyword(s):

Stem Cell ◽

Acute Lymphoblastic Leukemia ◽

Cell Transplantation ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL

Leukemia ◽

10.1038/sj.leu.2402552 ◽

2002 ◽

Vol 16 (9) ◽

pp. 1668-1672 ◽

Cited By ~ 128

Author(s):

P Bader ◽

J Hancock ◽

H Kreyenberg ◽

NJ Goulden ◽

D Niethammer ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Residual Disease ◽

Powerful Predictor ◽

Transplant Outcome ◽

Post Transplant ◽

WT1 Expression in Circulating RNA as a Minimal Residual Disease Marker for AML Patients After Stem-Cell Transplantation

Molecular Diagnosis & Therapy ◽

10.1007/s40291-015-0147-2 ◽

2015 ◽

Vol 19 (4) ◽

pp. 205-212 ◽

Cited By ~ 4

Author(s):

Ling Zhong ◽

Lingling Wei ◽

Jiao Chen ◽

Xiaobing Huang ◽

Yuping Gong ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Residual Disease ◽

Disease Marker ◽

Circulating Rna ◽

Quantitative Monitoring of Minimal Residual Disease after Allogeneic Stem Cell Transplantation in Relapsed Childhood ALL Allows the Identification of Impending Relapse – Results of the ALL BFM SCT 2003 Trial

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.12.108 ◽

2014 ◽

Vol 20 (2) ◽

pp. S85-S86

Author(s):

Peter Bader ◽

Hermann Kreyenberg ◽

Arend von Stackelberg ◽

Cornelia Eckert ◽

Roland Meisel ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Residual Disease ◽

Childhood All ◽

Quantitative Monitoring ◽

Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation

Experimental Hematology ◽

10.1016/j.exphem.2008.09.014 ◽

2009 ◽

Vol 37 (1) ◽

pp. 135-142 ◽

Cited By ~ 51

Author(s):

Ulrike Bacher ◽

Anita Badbaran ◽

Boris Fehse ◽

Tatjana Zabelina ◽

Axel Rolf Zander ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Residual Disease ◽

Quantitative Monitoring ◽

Disease Parameter ◽

Allogeneic stem cell transplantation for chronic lymphocytic leukemia: Lessons to be learned from minimal residual disease studies

Blood Reviews ◽

10.1016/j.blre.2011.01.001 ◽

2011 ◽

Vol 25 (2) ◽

pp. 91-96 ◽

Cited By ~ 34

Author(s):

Sebastian Böttcher ◽

Matthias Ritgen ◽

Peter Dreger

Keyword(s):

Stem Cell ◽

Chronic Lymphocytic Leukemia ◽

Cell Transplantation ◽

Residual Disease ◽

Lymphocytic Leukemia ◽